In addition to studying the effects of combined radiotherapy with anti-CTLA-4 treatments, preclinical studies suggest that radiotherapy and anti-PD-1/L1 therapy synergistically potentiate antitumor immunity in murine breast cancer models (178–180). This evidence concerns the gene CTLA4 and breast cancer.